News

Simmons First National Corporation Increases Dividend to $0.21

Simmons First National Corporation Increases Dividend to $0.21

Simmons First National Corporation Increases Dividend Amount

Simmons First National Corporation has made a significant announcement regarding its commitment to shareholders. The company declared a quarterly cash dividend of $0.21 per share on its Class A common stock. This marks a considerable achievement in corporate governance and financial stability.

Continuous Dividend Payments Over 115 Years

Since its establishment, Simmons First National Corporation has upheld its promise to shareholders by consistently paying dividends. This year, they proudly celebrate their 115th consecutive year of cash dividend payments. This track record reinforces their dedication to providing value to investors.

Dividend Payment Details

The upcoming dividend payment is scheduled for January 2, 2025, and is directed to shareholders of record as of December 13, 2024. This $0.21 per share dividend reflects an increase of $0.01 from the previous year, demonstrating the company's growth amidst ever-changing economic conditions.

Strong Financial Performance and Historical Significance

The annual cash dividend rate now stands at $0.84 for 2024, representing a remarkable ten-year compound annual growth rate of 6%. The longevity and consistency of dividend payments put Simmons in a prestigious category of companies. Research indicates that Simmons is one of only 26 publicly traded U.S. companies that have managed to maintain uninterrupted dividends for over a century.

Recognitions and Accolades

Simmons First National Corporation has received significant accolades highlighting its corporate reliability. The company earned the designation of a "Dividend Contender" — a title reflecting its success in increasing dividends for over a decade. This recognition stems from research that identifies Simmons among the few companies listed on the New York Stock Exchange and NASDAQ that have consistently met this standard.

About Simmons First National Corporation

Simmons First National Corporation (NASDAQ: SFNC) operates as a prominent financial holding company in the Mid-South. Their principal subsidiary, Simmons Bank, has an impressive presence with 234 branches spanning various neighboring states, providing various banking services with a client-centric philosophy.

Commitment to Exceptional Service

Founded in 1903, Simmons Bank is not just a financial institution; it has established itself as a reliable partner for its customers. Its commitment to delivering comprehensive financial solutions allows it to stand tall in the industry. In recognition of its workplace environment, Simmons Bank has been acknowledged by reputable sources like U.S. News & World Report and Forbes as one of the best employers and banks in recent reports.

Future Perspective

Simmons First National Corporation's ongoing success can be attributed to its strategic approach and dedication to shareholder value. However, it is common for companies to face various risks and uncertainties that could influence future dividend declarations. While past performance provides a solid foundation, future dividends ultimately depend on the company’s board of directors and their assessment of the prevailing economic conditions.

Frequently Asked Questions

What is the declared dividend amount per share by Simmons First National Corporation?

The company has declared a quarterly cash dividend of $0.21 per share on its Class A common stock.

How long has Simmons First National Corporation been paying dividends?

Simmons has been paying cash dividends for an impressive 115 consecutive years.

When will the dividend be paid, and who is eligible?

The dividend will be paid on January 2, 2025, to shareholders of record as of December 13, 2024.

What is the annual cash dividend rate for 2024?

The annual cash dividend rate for 2024 has been set at $0.84.

What recognitions has Simmons First National Corporation received?

Simmons has been recognized as a "Dividend Contender" and continues to be acknowledged for its outstanding service as a leading bank in various states.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles